首页> 外文期刊>Sleep & breathing =: Schlaf & Atmung >Treatment of obstructive sleep apnea syndrome in patients from a teaching hospital in Brazil: is it possible?
【24h】

Treatment of obstructive sleep apnea syndrome in patients from a teaching hospital in Brazil: is it possible?

机译:巴西一家教学医院对阻塞性睡眠呼吸暂停综合症的治疗:有可能吗?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of this study was to evaluate the efficacy of a cost-effective intra-oral appliance for obstructive sleep apnea syndrome built into a large teaching hospital. MATERIALS AND METHODS: Out of 20 evaluated and treated patients, 14 concluded the study: eight men and six women, with a mean age of 42-46 (mean + SD) years and mean body mass index of 27.66. Inclusion criteria were mild or moderate apnea-hypopnea index (AHI) according to a polysomnographic study. All patients were treated with the monobloco intra-oral appliance. They were then submitted to a follow-up polysomnographic study after 60 days using the appliance. An orofacial clinical evaluation was carried out with the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) questionnaire and with clinical evaluation questionnaire devised by the Orofacial Pain Team before and 60 days after fitting the intra-oral appliance. RESULTS: The AHI showed a statistically meaningful (p = 0.002) reduction from 15.53 to 7.82 events per hour, a non-statistically significant oxygen saturation increase from 83.36 to 84.86 (p = 0.09), and Epworth's sleepiness scale reduction from 9.14 to 6.36 (p = 0.001). Three patients did not show any improvement. The most common side effect during the use of the appliance/device was pain and facial discomfort (28.57%), without myofascial or temporomandibular joint pain as evaluated by the RDC/TMD questionnaire. CONCLUSIONS: The intra-oral device produced a significant reduction of the apnea-hypopnea index during the study period with the use of the monobloco intra-oral appliance. Patients did not show prior myofascial pain or 60 days after use of the intra-oral appliance.
机译:目的:本研究的目的是评估在大型教学医院中建立的一种成本有效的口腔内矫治器对阻塞性睡眠呼吸暂停综合症的疗效。材料与方法:在20位经过评估和治疗的患者中,有14位完成了研究:8位男性和6位女性,平均年龄为42-46(平均+ SD)岁,平均体重指数为27.66。根据一项多导睡眠图研究,纳入标准为轻度或中度呼吸暂停低通气指数(AHI)。所有患者均接受monobloco口腔内矫治器治疗。然后在使用该设备60天后将其接受后续多导睡眠监测研究。在安装口腔内矫治器之前和之后60天,根据《颞下颌疾病研究诊断标准》(RDC / TMD)问卷和Orofacial Pain Team设计的临床评估问卷进行了口腔临床评估。结果:AHI显示从每小时15.53事件减少到7.82事件具有统计学意义(p = 0.002),氧饱和度从83.36增加到84.86(p = 0.09)无统计学意义,爱泼华的嗜睡量表从9.14减少到6.36( p = 0.001)。 3例患者无任何改善。根据RDC / TMD调查表评估,在使用设备/装置期间,最常见的副作用是疼痛和面部不适(28.57%),而没有肌筋膜或颞下颌关节痛。结论:在研究期间,通过使用整体式口腔内矫治器,口腔内装置显着降低了呼吸暂停低通气指数。患者没有表现出先前的肌筋膜疼痛或使用口腔内矫治器后60天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号